Movano is in the development-stage and is developing a platform to deliver purpose-driven healthcare solutions at the intersection of medical and consumer devices. Co.'s solutions are being developed to provide vital health information, including heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, calories as well as glucose and blood pressure data, in a variety of form factors. Co.'s initial commercial product in development is the Evie Ring, which is a wearable designed specifically for women. Co. is also developing a small proprietary System-on-a-Chip designed specifically for blood pressure or continuous glucose monitoring systems. The MOVE average annual return since 2021 is shown above.
The Average Annual Return on the MOVE average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether MOVE average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the MOVE average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|